Last reviewed · How we verify
blood sample
A blood sample is a diagnostic specimen collected for laboratory analysis to assess health status, detect diseases, or monitor treatment.
At a glance
| Generic name | blood sample |
|---|---|
| Also known as | Salivary sicca syndrome will be evaluated., Saliva fluid will be collected., Ocular sicca syndrome will be evaluated., A conjonctival cytological impression will be done., questionnaire |
| Sponsor | Hospices Civils de Lyon |
| Modality | Biologic |
| Phase | FDA-approved |
Mechanism of action
A blood sample is not a pharmaceutical drug but rather a biological specimen obtained through venipuncture for clinical or research purposes. It is used to perform various tests including hematology, chemistry, microbiology, and immunology to diagnose conditions, monitor therapeutic drug levels, or assess organ function.
Approved indications
Common side effects
Key clinical trials
- Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure (NA)
- Collection of Blood From Patients With Prostate Cancer
- The Effect of Continuous Positive Airway Therapy on the Blood Pressure in Sleepy vs Non-sleepy Patients With Obstructive Sleep Apnea
- Screening and Multiple Intervention on Lung Epidemics (PHASE2)
- Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction (PHASE4)
- Efficacy of Nigella Sativa (Nisatol®) in Women With Borderline Blood Pressure Values or a Non-Dipper Blood Pressure Phenotype (NA)
- Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer (PHASE2)
- Study of New Magnetic Resonance Imaging Methods of the Brain
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- blood sample CI brief — competitive landscape report
- blood sample updates RSS · CI watch RSS
- Hospices Civils de Lyon portfolio CI